Effects of Ginkgo Biloba Extract on Impairment of Learning Induced by Cerebral Ischemia in Mice

American Journal of Chinese Medicine

Volumn 26, Issue 2, 1998, Pages 127-132

  Tadano, Takeshi ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PLANT EXTRACT;

AMNESIA; ANIMAL; ARTICLE; AVOIDANCE BEHAVIOR; BRAIN ISCHEMIA; DRUG EFFECT; GINKGO BILOBA; MALE; MEDICINAL PLANT; MOUSE; PHYTOTHERAPY;

AMNESIA; ANIMALS; AVOIDANCE LEARNING; BRAIN ISCHEMIA; GINKGO BILOBA; MALE; MICE; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL;

EID: 0032240165     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X98000178     Document Type: Article

References (17)

1. Braquet, P. (Ed.) Gingkolides: Chemistry, biology, pharmacology and clinical perspectives. Vol. 1. Barcelona: J.R. Prous, 1988.
2. Braquet, P. and D. Hosford. Ethnopharmacology and the development of natural PAF antagonists as therapeutic agents. J. Ethnopharmacol, 32: 135-139, 1991.
3. Chopra, K., M. Singh, S. Gupta and N.K. Ganguly. Involvement of oxygen free radicals in the action of BN 52021 (PAF antagonists) to limit myocardial infarct size. Meth. Find. Exp. Clin. Pharmacol. 15: 437-445,1993.
4. DeFeudis, F.V. Ginkgo biloba extract (EGb 761): Pharmacological Activities and Clinical Applications. Paris: Elsevier, 1991, p 187.
5. Eckmann, F. Hirnleistungsstorungen-Behandlung mit Gingko-biloba-Extrakt. Fortschr. Med., 108: 557-560,1990.
6. Heiss, W. D. and K. Zeiler. The influence of drugs on cerebral blood flow. Pharmacotherapy, 1: 137-144, 1978.
7. Janssers, D., C. Michiels, E. Délaive, F. Eliaers, K. Drieu and J. Remacl. Protection of hypoxiainduced-ATP decrease in endothelial cells by Gingko biloba extract and bilobalide. Biochem. Pliannacol, 50: 991-999, 1995.
8. Kleijnen, J. and P. Knipschild. Gingko biloba for cerebral insufficiency. Br. J. Clin. Pharmacol., 34: 352-358,1992a.
9. Kleijnen, J. and P. Knipschild. Drug Profiles. Gingko biloba. Lancet, 340: 1136-1139, 1992b.
10. Meyer, B. Etude multicentrique randomisée a double insu face au placebo du traitement des acouphenes par l'extrait de Gingko biloba. Presse Med., 15: 1562-1564, 1986.
11. Middleton, E., Jr. The flavonoids. Trends Pharmacol. Sei. 5: 335-338, 1984.
12. Pincemail, J. and C. Deby. The antiradical properties of Gingko biloba extract .In: Gingko biloba, Recent Results in Pharmacology and Clinic. (Ed. by E. W. Funfgeld). Berlin, Heidelberg, New York: Springer-Verlag, 1988, p 71-82.
13. Rapin J.R., P. Provost, F. DeFeudis and K. Drieu. Effects of repeated treatment with an extract of Gingko biloba (EGb 761) and bilobalide on glucose uptake and glycogen synthesis in rat erythrocytes. An ex vivo study. Drug Dev. Res., 31:164-169,1994.
14. Spinnewyn, B., N. Blavet and K. Drieu. Effect of Gingko biloba extract (EGb 761 ) on oxygen consumption by isolated cerebral mitochondria. In: Advances in Gingko biloba Extract (EGb 761) on Aging and Age-related Disorders. Paris: Elsevier, 1995, p 17-22.
15. Taylor, J.E. The effect of chronic, oral Gingko biloba extract administration on neurotransmitter receptor binding in young and aged Fisher 344 rats. In: Gingko biloba, Recent Results in Pharmacology and Clonic. (Ed. by E.W. Funfgeld). Berlin, Heidelberg: Springer Verlag, 1988, p 107-111.
16. Warburton, D.M. Psychopharmacologie clinique de l'extrait de Gingko biloba. Presse Med., 15: 1595-1604, 1986.
17. Welsh, F.A., T. Sakamoto, A.E. McKee and R.E. Sims. Effect of lactacidosis on pyridine nucleotide stability during ischemia in mouse brain. J. Neurochem., 49: 846-861, 1987.